Your browser is no longer supported. Please, upgrade your browser.
NRx Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-7.60 Insider Own1.30% Shs Outstand41.73M Perf Week-11.20%
Market Cap573.41M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float16.39M Perf Month-23.24%
Income-298.50M PEG- EPS next Q- Inst Own4.40% Short Float13.78% Perf Quarter-27.99%
Sales- P/S- EPS this Y-596.10% Inst Trans- Short Ratio0.46 Perf Half Y-62.78%
Book/sh-0.42 P/B- EPS next Y- ROA- Target Price- Perf Year-1.65%
Cash/sh0.25 P/C42.79 EPS next 5Y- ROE- 52W Range8.39 - 76.99 Perf YTD-56.15%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-86.10% Beta0.07
Dividend %- Quick Ratio0.50 Sales past 5Y- Gross Margin- 52W Low27.53% ATR1.67
Employees2 Current Ratio0.50 Sales Q/Q- Oper. Margin- RSI (14)40.53 Volatility11.39% 10.59%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.30 Prev Close10.50
ShortableYes LT Debt/Eq- EarningsAug 16 AMC Payout- Avg Volume4.91M Price10.70
Recom- SMA20-19.50% SMA50-22.29% SMA200-57.33% Volume1,477,751 Change1.90%
Sep-08-21 07:48AM  
Aug-30-21 08:06AM  
Aug-26-21 06:48AM  
Aug-25-21 09:43AM  
Aug-24-21 06:48AM  
Aug-23-21 09:33AM  
Aug-19-21 09:17AM  
Aug-18-21 11:53AM  
Aug-16-21 09:32PM  
Aug-11-21 04:20PM  
Aug-10-21 06:48AM  
Aug-09-21 01:13PM  
Aug-04-21 06:48AM  
Jul-27-21 11:34AM  
Jul-22-21 06:48AM  
Jul-19-21 06:48AM  
Jul-12-21 11:18AM  
Jul-06-21 09:20AM  
Jun-15-21 07:33AM  
Jun-09-21 02:50PM  
Jun-08-21 02:03PM  
Jun-07-21 01:45PM  
Jun-01-21 06:28AM  
May-27-21 06:48AM  
May-26-21 09:29AM  
NRx Pharmaceuticals, Inc. a clinical-stage, small molecule pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was incorporated in 2015 and is headquartered in Wilmington, Delaware.